Clin2
NCT06657924Possibly a fitRecruiting

TXA to Prevent Bleeding in Colorectal Surgery

BleedingColorectal DisordersThromboembolismTranexamic Acid

Treatments studied

Part of Heart & circulation clinical trials.

This trial tests a medicine called tranexamic acid (TXA) given right before major colorectal surgery to see if it helps reduce bleeding. If it works, it could make surgery safer for people like you.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
394 people
Ages
18 years to 100 years
Study type
Interventional

Who can take part

  • You must be 18 or older.
  • You are scheduled for major colorectal surgery (on your colon or rectum) that requires a hospital stay.
  • You cannot have severe kidney disease (creatinine clearance < 30) or be on dialysis.
  • You cannot be color blind.
  • You cannot be pregnant.
  • You cannot have a history of blood clots or a clotting disorder like DIC.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05047133Recruiting· Phase 2/Phase 3
Early TXA treatment for adult hip fracture surgery

This study tests whether giving a blood-clot-reducing medicine (TXA) early after an adult hip fracture helps reduce bleeding and related problems around surgery. It may help some patients getting operative fixation by improving safety during recovery.

Grand Blanc, Michigan
NCT05345613Recruiting· Phase 4
Tranexamic acid during colon scope removal procedures

This trial tests whether tranexamic acid (a medicine that helps reduce bleeding) lowers bleeding during colon procedures where abnormal growths are removed with a flexible camera. You might benefit if you’re having one of these colonoscopic resection procedures and don’t have certain key risk factors.

Be’er Ya‘aqov
NCT04312880Enrolling by invitation· Phase 4
Tranexamic acid during elective back surgery to reduce bleeding

This trial studies whether giving tranexamic acid (a medicine that helps reduce bleeding) during planned lower-back decompression surgery can lower blood loss or related complications. It compares patients who receive the infusion during surgery to those who meet study procedures and safety requirements.

Albany, New York
NCT05806346Recruiting
TXA dosing for heart surgery patients on bypass

This trial studies whether giving tranexamic acid (TXA) based on patient needs during heart surgery works better than a one-size-fits-all approach. It may help reduce bleeding during surgery, while monitoring for clotting-related side effects.

Seoul
NCT02314988Recruiting· Phase 2/Phase 3
Tranexamic acid to reduce bleeding in spine surgery

This trial tests whether tranexamic acid (a medicine that helps blood clot) can reduce blood loss during long spine surgery after an injury. It may help lower the chance of needing transfusions and manage surgical bleeding.

San Francisco, California
NCT07460518Recruiting· Phase 4
Tranexamic acid for reducing bleeding during prostate surgery

This trial tests whether a medicine called tranexamic acid, given during surgery to remove part of the prostate, can reduce bleeding. If you are scheduled for this type of prostate surgery, this treatment might help make the procedure safer and improve recovery.

Rabat

Hear when a new Bleeding trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.